Skip to main content
| News

LCB lands major contract

11.06.2021

LCB Sàrl has developed i4, a communication module for machines at the service of Industry 4.0. The Jura-based company has created a partnership with the French group HLP, which specializes in the digital transformation of companies. This success is also the result of the Basel Area Business & Innovation network.

David Maître, founder of LCB (right), with Albert Hilber from i4Challenge (img: Dave Joly)

LCB Sàrl has developed i4, a communication module for machines at the service of Industry 4.0. The Jura-based company has created a partnership with the French group HLP, which specializes in the digital transformation of companies. This success is also the result of the Basel Area Business & Innovation network.

The agency for the promotion of the business location and innovation organizes the i4Challenge, a competition for start-ups and SMEs in the Industry 4.0 sector. As one of the winners in 2019, LCB Sàrl was thus able to participate in the tri-national Industry 4.0 trade fair (BE4.0) in Mulhouse. It was on this occasion that the meeting with HLP took place. “If while walking around the BE4.0 fair, I had not decided to stop at the HLP booth, none of this would have happened,” recalls David Maître of LCB.

Within the framework of the partnership with HLP, LCB has already been able to win new customers. These include a multinational group with more than 40 production sites in America, the EU and Asia. For LCB, this represents more than 1500 boxes and therefore more than 1500 machines to connect.

David Maître founded LCB Sàrl in 1997. “We have been evolving in the field of Industry 4.0 for over 20 years. Only it wasn’t called that back then,” David Maître said in an interview on the occasion of his victory at i4Challenge 2019. His company solves “industry-related technical problems where standard solutions don’t apply, or where processes need to be adjusted.” With its i4 modules, LCB Sàrl wants to propose to companies its solutions for the communication of production means.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

BeiGene opens European headquarters in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

BeiGene opens European headquarters in Basel

BeiGene has opened its new European headquarters in Basel. The global biotech specializing in innovative cancer treatments intends to build...

Read More
The 25 Best AI Courses in the Basel Area, Germany and France
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation

The 25 Best AI Courses in the Basel Area, Germany and France

Artificial Intelligence (AI) offers numerous possible applications. But how, where and regarding which focal points can you get further training...

Read More
Engimmune Therapeutics banks 15.5 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Engimmune Therapeutics banks 15.5 million Swiss francs

Engimmune Therapeutics will now be in a position to drive forward its innovative platforms for the development of T-cell therapies...

Read More
Bionter receives 3 million US dollars in investments
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Bionter receives 3 million US dollars in investments

Bionter AG has received 3 million US dollars in a seed funding round. These funds will enable Bionter to bring...

Read More
Resistell seeking to further develop test to combat antibiotic resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Resistell seeking to further develop test to combat antibiotic resistance

The startup Resistell has launched a study looking into the applicability of a test against antibiotic resistances that is being...

Read More
Biotech startup Cimeio receives 46 million Swiss francs for cell therapy
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Biotech startup Cimeio receives 46 million Swiss francs for cell therapy

Cimeio Therapeutics from Basel has received initial financing amounting to 46 million Swiss francs from Versant Ventures. The startup is...

Read More
1 2 3 55

Do you have a question? We'd like to hear from you.